Changing incidence of myeloproliferative neoplasms in Australia, 2003-2014

Peter D. Baade* (Corresponding Author), David M. Ross, Lesley A. Anderson, Cecily Forsyth, Lin Fritschi

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

13 Citations (Scopus)


The Philadelphia‐negative myeloproliferative neoplasms (MPNs) include three clinical entities commonly referred to as the “classic” MPNs: polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). In comparison to other cancer types, epidemiological data for these cancers are sparse. We report here the latest available statistics on incidence, prevalence, and survival of MPN in Australia.
Original languageEnglish
Pages (from-to)E107-E109
Number of pages3
JournalAmerican Journal of Hematology
Issue number4
Early online date12 Feb 2019
Publication statusPublished - Apr 2019


Dive into the research topics of 'Changing incidence of myeloproliferative neoplasms in Australia, 2003-2014'. Together they form a unique fingerprint.

Cite this